title: Lacquer cracks developing after phakic intraocular lens implantation.
abstract: OBJECTIVE
  To describe a case of lacquer cracks developing after phakic intraocular lens implantation.
  
  
  METHODS
  Case report.
  
  
  RESULTS
  A 46-year-old woman diagnosed as having extreme myopia and corrected distance visual acuity of 20/40 presented with decreased vision and a central scotoma less than 24 hours following phakic intraocular lens implantation. Dilated examination revealed the presence of a macular hemorrhage and possible lacquer crack formation. Documented preoperative imaging showed an absence of lacquer cracks in the eye that was operated on. The patient was treated with intravitreal bevacizumab. At 4 weeks postoperatively, imaging confirmed an almost complete resolution of the hemorrhagic pigment epithelial detachment with evidence of lacquer cracks. Uncorrected visual acuity was 20/50 and the patient was asymptomatic.
  
  
  CONCLUSIONS
  This is the first reported case of macular crack formation immediately following phakic intraocular lens implantation. Possible contributing factors are discussed.
authors.forename: Simon
authors.initials: S
authors.lastname: Chen
authors.forename: Chris
authors.initials: C
authors.lastname: Hodge
authors.forename: Gerard
authors.initials: G
authors.lastname: Sutton
authors.forename: Patrick
authors.initials: P
authors.lastname: Versace
authors.forename: Dip
authors.initials: D
authors.lastname: Anaes
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000068258:Bevacizumab; D005260:Female; D006801:Humans; D058449:Intravitreal Injections; D019654:Lens Implantation, Intraocular / Q000009:adverse effects*; D008875:Middle Aged; D009216:Myopia / Q000601:surgery; D054120:Phakic Intraocular Lenses; D012164:Retinal Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D012166:Retinal Hemorrhage / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D012607:Scotoma / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab